BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 8082439)

  • 1. [Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus].
    Shi YF; Xie X; Zhao CL
    Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):201-4, 251. PubMed ID: 8082439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases.
    Burns B; Curry RH; Bell ME
    Am J Obstet Gynecol; 1979 Sep; 135(1):109-14. PubMed ID: 474641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases.
    Lee TK; Miyamoto H; Osunkoya AO; Guo CC; Weiss SW; Epstein JI
    Am J Surg Pathol; 2010 Apr; 34(4):502-9. PubMed ID: 20154594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
    Ip PP; Tse KY; Tam KF
    Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of calponin h1 in leiomyosarcoma of the uterus.
    Horiuchi A; Nikaido T; Ito K; Zhai Y; Orii A; Taniguchi S; Toki T; Fujii S
    Lab Invest; 1998 Jul; 78(7):839-46. PubMed ID: 9690561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
    Bell SW; Kempson RL; Hendrickson MR
    Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic considerations of uterine smooth muscle tumors.
    Prayson RA; Hart WR
    Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of chemokines CCL5 and CCL11 by smooth muscle tumor cells of the uterus and its possible role in the recruitment of mast cells.
    Zhu XQ; Lv JQ; Lin Y; Xiang M; Gao BH; Shi YF
    Gynecol Oncol; 2007 Jun; 105(3):650-6. PubMed ID: 17368523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
    Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
    J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.
    Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB
    Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bizarre leiomyoma of the uterus--a clinicopathological analysis of 21 cases].
    Zhao ZS
    Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):441-3. PubMed ID: 2076641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Border-line smooth-muscle tumor of the uterus: analysis of 131 patients].
    Ma SK; Zhang HT; Wu LY; Liu LY; Li B
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):698-700. PubMed ID: 16438896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous leiomyoma with cytologic atypia, akin to uterine symplastic leiomyoma.
    Matthews JH; Pichardo RO; Hitchcock MG; Leshin B
    Dermatol Surg; 2004 Sep; 30(9):1249-51; discussion 1251. PubMed ID: 15355371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
    Mittal K; Demopoulos RI
    Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symplastic leiomyomas of the scrotum: a comparative study to usual leiomyomas and leiomyosarcomas.
    Matoso A; Chen S; Plaza JA; Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2014 Oct; 38(10):1410-7. PubMed ID: 24832157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
    Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspiration biopsy cytology of smooth muscle tumors. A cytologic approach to the differentiation between leiomyosarcoma and leiomyoma.
    Tao LC; Davidson DD
    Acta Cytol; 1993; 37(3):300-8. PubMed ID: 8498132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Smooth muscle neoplasms of the uterus--a 51 cases study].
    Wang M; Xu Y; Zhang T
    Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):263-5. PubMed ID: 9388867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.